This article has Open Peer Review reports available.
Visually augmented targeted combination light therapy for acne vulgaris: a case report
© The Author(s). 2017
Received: 15 May 2017
Accepted: 20 September 2017
Published: 31 October 2017
Acne vulgaris is a common skin disease. Pharmacological modalities for treatment are proven to be efficacious but have limitations. Light therapy for acne vulgaris has shown promise in previous studies. This case report and its accompanying images show how a novel approach of visually augmented high fluence light therapy has been used to good effect.
A 26-year-old Caucasian woman with acne vulgaris resistant to treatment with topical therapy underwent three sessions of combination potassium titanyl phosphate laser (532 nm)/neodymium-doped: yttrium aluminum garnet laser (1064 nm) light therapy with visually augmented narrow spot size and high fluence. A 73% reduction in total inflammatory lesions was evident 6 months after the initial treatment.
This case report illustrates that there may be utility in this novel approach of narrow spot size, magnification-assisted, high fluence targeted combination laser therapy for inflammatory acne.
Acne vulgaris is a common skin disease affecting 90% of people at some time in their lives, to varying degrees. It can have a profound psychological impact on the patient, often out of proportion from the perceived physical effect.
Established medical treatment for acne includes topical application of benzoyl peroxide, topical and oral antibiotics, and systemic retinoids for severe or resistant acne. Although proven to be efficacious, these treatments have disadvantages that limit their use. Systemic retinoids are teratogenic and have systemic side effects, while non-compliance is an issue with topical treatment. There is also the problem of growing antibiotic resistance of the Cutibacterium acnes organism that contributes to inflammation in acne .
There has been recent interest in the role of light therapy in acne. A recent Cochrane review concluded that high quality evidence was lacking, but that treatment with green light was more effective than placebo . There have been a number of promising results from studies on a range of energy-based devices .
The following case illustrates an approach to using phototherapy for acne that uses a novel combination of narrow spot size wavelengths with high energy level phototherapy under visual magnification to achieve a 73% reduction in inflammatory lesions. A literature search of acne phototherapy indicates that this is a unique approach that merits further investigation.
Three treatments in total of combination non-ablative laser therapy were applied; each session was held 2 to 3 weeks apart. We used a combination of treatment with high fluence potassium titanyl phosphate (KTP) and neodymium-doped: yttrium aluminum garnet (Nd:YAG) laser.
KTP laser settings of 532 nm, high fluence 20 J/cm2, 20 millisecond pulse width, 1 mm2 spot size, and 2 Hz pulse rate were used superficially, targeting the oxyhemoglobin within the pilosebaceous unit. Nd:YAG laser settings of 1064 nm, 150 to 250 J/cm2, 55 to 75 millisecond pulse width, and 1 mm2 spot size were used to eradicate the base of a hair follicle on a deeper level of the dermis along with any des-oxyhemoglobin resulting from the more superficial treatment. No topical sensitizer was used. Polarized visual magnification with a 5× headset magnification was used to assist with identification of lesions. External sclera shields were applied to our patient during treatment.
The method of phototherapy used in this case aims to precisely target the infected pilosebaceous unit with a narrow spot size green laser using visual augmentation, thus limiting damage to adjacent tissue. An infrared laser is used to target melanin in a deeper layer and resolve the mottled appearance of des-oxyhemoglobin following superficial treatment.
Studies on the use of green light (495 to 570 nm) in the treatment of acne have treated the entire surface of the designated treatment side, or with a notably larger spot size, no visual augmentation, and lower fluence. Baugh and Kucaba demonstrated efficacy with 12 J/cm2 fluence treatment of the entire surface of the designated treatment side . Yilmaz et al. used 5 to 12 J/cm2 fluence with a 4 mm spot size. Neither used magnification aid .
Combination laser therapy of different wavelengths of the green and infrared spectrum have been shown to be safe and effective in pulsed dye lasers (PDL)  with a postulated synergistic mechanism of action accounting for increased efficacy versus monophasic treatment. A literature search found no comparable studies for the KTP/Nd:YAG combination used in this case.
This case study represents a unique instance of combination KTP laser (532 nm)/Nd:YAG laser (1064 nm) light therapy with visually augmented narrow spot size and high fluence. The outcome of this case indicates that this treatment method is a candidate for further research.
Optimal parameters in phototherapy for acne are yet to be established. This case illustrates that there may be utility in this novel approach of narrow spot size and magnification-assisted targeted combination laser therapy for inflammatory acne that merits further investigation.
Imperial College London is grateful for support from the NW London NIHR Collaboration for Leadership in Applied Health Research & Care.
Availability of data and materials
The images supporting the conclusion of this case report are included within the article. Additional images used to calculate the total reduction of inflammatory papules available on request.
CL managed the patient and performed the follow-up. AY wrote the initial manuscript, with revision and major contributions from CL and NR. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
CL is the medical director of a laser clinic limited company.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840–8.View ArticlePubMedGoogle Scholar
- Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2017. doi:10.1111/bjd.15495.PubMedGoogle Scholar
- Handler MZ, Bloom BS, Goldberg DJ. Energy-Based Devices in Treatment of Acne Vulgaris. Dermatol Surg. 2016;42:573–85.View ArticlePubMedGoogle Scholar
- Draft Guidance for Industry - Acne Vulgaris: Developing Drugs for Treatment. Rockville: United States Food and Drug Administration; 2005.Google Scholar
- Baugh WP, Kucaba WD. Nonablative Phototherapy for Acne Vulgaris Using the KTP 532 nm Laser. Dermatol Surg. 2005;31:1290–6.View ArticlePubMedGoogle Scholar
- Yilmaz O, Senturk N, Yuksel EP, et al. Evaluation of 532-nm KTP laser treatment efficacy on acne vulgaris with once and twice weekly applications. J Cosmet Laser Ther. 2011;13:303–7.View ArticlePubMedGoogle Scholar
- Jung JY, Choi YS, Yoon MY, Min SU, Suh DH. Comparison of a Pulsed Dye Laser and a Combined 585/1,064-nm Laser in the Treatment of Acne Vulgaris. Dermatol Surg. 2009;35:1181–7.View ArticlePubMedGoogle Scholar